Abstract
Apoptosis is an increasingly well described, but still poorly understood, mechanism for killing metazoan cells (Kerr et al. 1972; Wyllie et al. 1980). It is fundamental to processes as diverse as tissue remodelling during embryogenesis, maintenance of tissue homeostasis in the adult and to both innate and cognate immunity (Ellis et al. 1991; Cohen et al. 1992; Raff 1992; Ameisen et al. 1994; Vaux et al. 1994; Strasser 1995b; Golstein 1997; Jacobson et al. 1997; Nagata 1997). Cells undergoing apoptosis exhibit characteristic changes in their appearance, notably plasma membrane blebbing and chromatin condensation (Kerr et al. 1972; Wyllie et al. 1980). Molecular indicators of apoptosis include internucleosomal DNA cleavage (Wyllie 1980), proteolysis of vital cellular substrates (Casciola-Rosen et al. 1996), externalisation of phosphatidyl-serine in the plasma membrane and expression of receptors that facilitate engulfment by phagocytes (Savill et al. 1993). Apoptosis can be caused by a broad range of physiological stimuli or experimentally applied stress conditions, and it appears that cells from all tissue types and from all multi-cellular organisms studied thus far possess this evolutionarily conserved death programme (Ellis et al. 1991; Raff 1992; Hengartner and Horvitz 1994c; Steller 1995; Vaux and Strasser 1996). Apoptosis can be induced via multiple independent pathways with distinct signalling intermediates. These routes all converge upon activation of latent cysteine proteases (caspases), leading to the proteolysis of vital cellular substrates and ultimately collapse of the cell (Vaux and Strasser 1996; Jacobson et al. 1997). Proteins of the Bd-2 family have been found to be key controllers of the cell death effector machinery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Acton D, Domen J, Jacobs H, Vlaar M, Korsmeyer S, Berns A (1992) Collaboration of PIM-1 and BCL-2 in lymphomagenesis. Curr Top Microbiol Immunol 182: 293–298
Adachi M, Suematsu S, Kondo T, Ogasawara J, Tanaka T, Yoshida N, Nagata S (1995) Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat Genet 11: 294–300
Ahmad M, Srinivasula SM, Wang LJ, Litwack G, Fernandes-Alnemri T, Alnemri ES (1997) Spodoptera frugiperda caspase-1, a novel insect death protease that cleaves the nuclear immunophilin fkbp46, is the target of the baculovirus antiapoptotic protein p35. J Biol Chem 272: 1421–1424
Aitken A (1995) 14–3–3 proteins on the MAP TIBS 20:95–97
Akashi K, Kondo M, von Freeden-Jeffry U, Murray R, Weissman IL (1997) Bd-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89: 1033–1041
Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH (1995) Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181: 71–77
Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J (1996) Human ICE/CED-3 protease nomenclature. Cell 87: 171
Ameisen JC, Estaquier J, Idziorek T (1994) From AIDS to parasite infection: pathogen-mediated subversion of programmed cell death as a mechanism for immune dysregulation. Immunol Rev 142: 9–51
Baffy G, Miyashita T, Williamson JR, Reed JC (1993) Apoptosis induced by withdrawal of interleukin-3 from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bd-2 oncoprotein production. J Biol Chem 268: 6511–6519
Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL, Korsmeyer SJ (1985) Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around J. on chromosome 14 and near a transcriptional unit on 18. Cell 41: 899–906
Beals CR, Clipstone NA, Ho SN, Crabtree GR (1997) Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction. Genes Dev 11: 824–834
Seidler DR, Tewari M, Friesen PD, Poirier G, Dixit VM (1995) The baculovirus p35 protein inhibits Fas-and tumor necrosis factor-induced apoptosis. J Biol Chem 270: 16526–16528
Bertin J, Mendrysa SM, LaCount DJ, Gaur S, Krebs JF, Armstrong RC, Tomaselli KJ, Friesen PD (1996) Apoptotic suppression by baculovirus p35 involves cleavage by and inhibition of a virus-induced CED-3/ICE-like protease. J Virol 70: 6251–6259
Bodmer J-L, Burns K, Schneider P, Hofmann K, Steiner V, Thome M, Bornand T, Hahne M, Schröter M, Becker K, Wilson A, French LE, Browning JL, MacDonald HR, Tschopp J (1997) TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor ecrosis factor receptor 1 and Fas (Apo-1/CD95). Immunity 6: 79–88
Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB (1993) bcl-x, a bc1–2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597–608
Boise LH, Minn AJ, June CH, Lindsten T, Thompson CB (1995) Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. Proc Natl Acad Sci USA 92: 5491–5495
Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D (1995) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270: 7795–7798
Boldin MP, Goncharov TM, Goltsev YV, Wallach D (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85: 803–815
Borner C, Martinou I, Mattmann C, Irmler M, Schaerer E, Martinou J-C, Tschopp J (1994) The protein bc1–2a does not require membrane attachment, but two conserved domains to suppress apoptosis. J Cell Biol 126: 1059–1068
Borzillo GV, Endo K, Tsujimoto Y (1994) bd-2 confers growth and survival advantage to interleukin 7-dependent early pre-B cells which become factor independent by a multistep process in culture. Oncogene 7: 869–876
Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B, D’Sa-Eipper C, Chinnadurai G (1994) Adenovirus E1B 19 kDa and Bd-2 proteins interact with a common set of cellular proteins. Cell 79: 341–351
Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery BJ, Ebb RG, Subramanian T, Chittenden T, Lutz RJ, Chinnadurai G (1995) Bik, a novel death-inducing protein shares a distinct sequence motif with Bd-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11: 1921–1928
Brady HJM, Gil-Gómez G, Kirberg J, Berns AJM (1996a) Baxa perturbs T cell development and affects cell cycle entry of T cells. EMBO J 15: 6991–7001
Brady HJM, Salomns GS, Bobeldijk RC, Berns AJM (1996b) T cells from baxa transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53. EMBO J 15: 1221–1230
Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373: 441–444
Bump NJ, Hackett M, Hugunin M, Seshagiri S, Brady K, Chen P, Ferenz C, Franklin S, Ghayur T, Li P, Licari P, Mankovich J, Shi L, Greenberg AH, Miller LK, Wong WW (1995) Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 269: 1885–1888
Carrió R, López-Hoyos M, Jimeno J, Benedict MA, Merino R, Benito MA, Fernandez-Luna JL, Núnez G, Garcia-Porrero JA, Merino J (1996) Al demonstrates restricted tissue distribution during embryonic development and functions to protect against cell death. Am J Pathol 149: 2133–2142
Casciola-Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK, Rosen A (1996) Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 183: 1957–1964
Chang BS, Minn AJ, Muchmore SW, Fesik SW, Thompson CB (1997) Identification of a novel regulatory domain in Bcl-x, and Bc1–2. EMBO J 16: 968–977
Chao DT, Linette GP, Boise LH, White LS, Thompson CB, Korsmeyer SJ (1995) Bcl-x(L) and Bc12 repress a common pathway of cell death. J Exp Med 182: 821–828
Chen G, Branton PE, Yang E, Korsmeyer SJ, Shore GC (1996) Adenovirus E1B 19-kDa death suppressor protein interacts with Bax but not with Bad. J Biol Chem 271: 24221–24225
Chen-Levy Z, Cleary ML (1990) Membrane topology of the Bd-2 proto-oncogenic protein dem-onstrated in vitro. J Biol Chem 265: 4929–4933
Chen-Levy Z, Nourse J, Cleary ML (1989) The bd-2 candidate proto-oncogene product is a 24kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation. Mol Cell Biol 9: 701–710
Cheng EH-Y, Levine B, Boise LH, Thompson CG, Hardwick JM (1996) Bax-independent inhibition of apoptosis by Bcl-x,.. Nature 379: 554–556
Cheng EH-Y, Nicholas J, Bellows DS, Hayward GS, Guo H-G, Reitz MS, Hardwick JM (1997) A Bd-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci USA 94: 690–694
Chinnaiyan AM, O’Rourke K, Tewari M, Dixit VM (1995) FADD, a novel death domain-contain-ing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505–512
Chinnaiyan AM, Orth K, O’Rourke K, Duan H, Poirier GG, Dixit VM (1996a) Molecular ordering of the cell death pathway. J Biol Chem 271: 4573–4576
Chinnaiyan AM, Tepper CG, Seldin MF, O’Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME, Dixit VM (1996b) FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 271: 4961–4965
Chinnaiyan AM, O’Rourke K, Lane BR, Dixit VM (1997) Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 275: 1122–1126
Chittenden T, Flemington C, Houghton AB, Ebb RG, Gallo GJ, Elangovan B, Chinnadurai G, Lutz RJ (1995a) A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J 14: 5589–5596
Chittenden T, Harrington EA, O’Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC (1995b) Induction of apoptosis by the Bd-2 homologue Bak. Nature 374: 733–736
Chung J, Deutsch HH, Kalthoff FS (1996) IL-4-dependent proliferation of BA/F3 cells expressing a growth-negative mutant of the human IL-4 receptor is restored by enforced expression of Bd-2. J Leuk Biol 59: 586–590
Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849–852
Clarke AR, Gledhill S, Hooper ML, Bird CC, Wyllie AH (1994) p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following ‘y-irradiation. Oncogene 9: 1767–1773
Cleary ML, Sklar J (1987) Formation of a hybrid bcl-2/immunoglobulin transcript as a result of t(14;18) chromosomal translocation. Hämatol Bluttransfus 31: 314–319
Cleary ML, Smith SD, Sklar J (1986) Cloning and structural analysis of cDNAs for bd-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47: 1928
Cohen JJ, Duke RC, Fadok VA, Sellins KS (1992) Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10: 267–293
Cory S (1995) Regulation of lymphocyte survival by the BCL-2 gene family. Annu Rev Immunol 13: 513–543
Cory S, Harris AW, Strasser A (1994) Insights from transgenic mice regarding the role of bd-2 in normal and neoplastic lymphoid cells. Proc R Soc Lond 345: 289–295
Datta R, Kojima H, Banach D, Bump NJ, Talanian RV, Alnemri ES, Weichselbaum RR, Wong WW, Kufe DW (1997) Activation of a CrmA-insensitive, p35-sensitive pathway in ionizing radiation-induced apoptosis. J Biol Chem 272: 1965–1969
de Jong D, Prins F, van Krieken HHJM, Mason DY, van Ommen G, Kluin PM (1992) Subcellular localization of bd-2 protein. Curr Top Microbiol Immunol 182: 287–292
de Jong D, Prins FA, Mason DY, Reed JC, van Ommen GB, Kluin PM (1994) Subcellular localiza- tion of the bd-2 protein in malignant and normal lymphoid cells. Cancer Res 54: 256–260
Deng G, Podack ER (1993) Suppression of apoptosis in a cytotoxic T-cell line by interleukin-2mediated gene transcription and deregulated expression of the protooncogene bd-2. Proc Natl Acad Sci USA 90: 2189–2193
Dhein J, Walczak H, Baumler C, Debatin K-M, Krammer PH (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373: 438–441
Diaz J-L, Oltersdorf T, Horne W, McConnell M, Wilson G, Weeks S, Garcia T, Fritz LC (1997) Acommon binding site mediates heterodimerization and homodimerization of Bd-2 family members. J Biol Chem 272: 11350–11355
Ellis HM, Horvitz HR (1986) Genetic control of programmed cell death in the nematode C. elegans. Cell 44: 817–829
Ellis RE, Yuan J, Horvitz HR (1991) Mechanisms and functions of cell death. Annu Rev Cell Biol 7: 663–698
Farlie PG, Dringen R, Rees SM, Kannourakis G, Bernard O (1995) bd-2 transgene expression can protect neurons against developmental and induced cell death. Proc Natl Acad Sci USA 92: 4397–4401
Farrow SN, White JHM, Martinou I, Raven T, Pun K-T, Grinham CJ, Martinou J-C, Brown R (1995) Cloning of a bd-2 homologue by interaction with adenovirus El B 19K. Nature 374: 731–733
Fernandez-Sarabia MJ, Bischoff JR (1993) Bd-2 associates with the ras-related protein R-ras p23. Nature 366: 274–275
Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middelton LA, Lin AY, Strober W, Lenardo MJ, Puck JM (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81: 935–946
Fraser AG, Evan GI (1997) Identification of a Drosophila melanogaster ICE/CED-3-related protease, drICE. EMBO J 16: 2805–2813
Furuchi T, Masuko K, Nishimune Y, Obinata M, Matsui Y (1996) Inhibition of testicular germ cell apoptosis and differentiation in mice misexpressing Bd-2 in spermatogonia. Development 122: 1703–1709
Garcia I, Martinou I, Tsujimoto Y, Martinou J-C (1992) Prevention of programmed cell death of sympathetic neurons by the bd-2 proto-oncogene. Science 258: 302–304
Gibson L, Holmgreen S, Huang DCS, Bernard O, Copeland NG, Jenkins NA, Sutherland GR, Baker E, Adams JM, Cory S (1996) bcl-w, a novel member of the bc1–2 family, promotes cell survival. Oncogene 13: 665–675
Golstein P (1997) Controlling cell death. Science 275: 1081–1082
Golstein P, Ojcius DM, Young D-E (1991) Cell death mechanisms and the immune system. Immunol Rev 121: 29–65
Gonzalez-Garcia M, Perez-Ballestero R, Ding L, Duan L, Boise LH, Thompson CB, Nunez G (1994) Bcl-X, is the major bd-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 120: 3033–3042
Graninger WB, Seto M, Boutain B, Goldman P, Korsmeyer SJ (1987) Expression of Bd-2 and Bc12–1g fusion transcripts in normal and neoplastic cells. J Clin Invest 80: 1512–1515
Gratiot-Deans J, Merino R, Nunez G, Turka LA (1994) Bd-2 expression during T-cell development: early loss and late return occur at specific stages of commitment to differentiation and survival. Proc Natl Acad Sci USA 91: 10685–10689
Grether ME, Abrams JM, Agapite J, White K, Steller H (1995) The head involution defective gene of Drosophila melanogaster functions in programmed cell death. Genes Dev 9: 1694–1708
Grillot DAM, Merino R, Nunez G (1995) Bcl-x,, displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J Exp Med 182: 1973–1983
Haecker G, Vaux DL (1994) Viral, worm and radical implications for apoptosis. Trends Biochem Sci 19: 99–100
Haldar S, Beatty C, Tsujimoto Y, Croce CM (1989) The bd-2 gene encodes a novel G protein. Nature 342: 195–198
Han J, Sabbatini P, Perez D, Rao L, Modha D, White E (1996a) The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev 10: 461–477
Han J, Sabbatini P, White E (1996b) Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K.Mol Cell Biol 16: 5857–5864
Hanada M, Aime-Sempe C, Sato T, Reed JC (1995) Structure-function analysis of Bd-2 protein. Identification of conserved domains important for homodimerization with Bd-2 and heterodimerization with Bax. J Biol Chem 270: 11962–11969
Hartley SB, Cooke MP, Fulcher DA, Harris AW, Cory S, Basten A, Goodnow CC (1993) Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72: 325–335
Hay BA, Wolff T, Rubin GM (1994) Expression of baculovirus p35 prevents cell death in Drosophila. Development 120: 2121–2129
Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A (1993) Epstein virus-coded BHRF 1 protein, a viral homologue of Bd-2 protects human B cells from programmed cell death. Proc Natl Acad Sci USA 90: 8479–8483
Hengartner MO, Horvitz HR (1994a) Activation of C. elegans cell death protein CED-9 by an amino-acid substitution in a domain conserved in Bd-2. Nature 369: 318–320
Hengartner MO, Horvitz HR (1994b) C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bd-2. Cell 76: 665–676
Hengartner MO, Horvitz HR (1994c) Programmed cell death in Caenorhabditis elegans. Curr Opin Genet Dev 4: 581–586
Hengartner MO, Ellis RE, Horvitz HR (1992) Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 356: 494–499
Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990) Bc1–2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334–336
Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer S (1991) BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88: 6961–6965
Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer S (1993) Bd-2 functions in an antioxidant pathway to prevent apoptosis. Cell 74: 241–251
Hsu H, Xiong J, Goeddel DV (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-xB activation. Cell 81: 495–504
Hsu H, Shu H-B, Pan M-G, Goeddel DV (1996) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299–308
Huang DCS, Cory S, Strasser A (1997) Bd-2 Bcl-x,, and adenovirus protein E1B19kD are function-ally equivalent in their ability to inhibit cell death. Oncogene 14: 405–414
Huang DCS, O’Reilly LA, Strasser A, Cory S (1997) The anti-apoptosis function of Bd-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J 16: 4638–4648
Inohara N, Ding L, Chen S, Núnez G (1997) harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bd-2 and Bcl-X,. EMBO J 16: 1686–1694
Ito T, Deng X, Carr B, May WS (1997) Bd-2 phosphorylation required for anti-apoptosis function. J Biol Chem 272: 11671–11673
Itoh N, Nagata S (1993) A novel protein domain required for apoptosis. J Biol Chem 268: 10932–10937
Jäättelä M, Benedict M, Tewari M, Shayman JA, Dixit VM (1995) Bd-x and Bd-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A, in breast carcinoma cells. Oncogene 10: 2297–2305
Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an Rb mutation in the mouse. Nature 359: 295–300
Jacobson MD, Raff MC (1995) Programmed cell death and Bc1–2 protection in very low oxygen. Nature 374: 814–816
Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC (1993) Bd-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361: 365–369
Jacobson MD, Weil M, Raff MC (1997) Programmed cell death in animal development. Cell 88: 347–354
Ju S-T, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373: 444–448
Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE (1993) Bd-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262: 1274–1277
Katsumata M, Siegel RM, Louie DC, Miyashita T, Tsujimoto Y, Nowell PC, Greene MI, Reed JC (1992) Differential effects of Bcl-2 on T and B cells in transgenic mice. Proc Natl Acad Sci USA 89: 11376–11380
Kerr JFR, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239–257
Kharbanda S, Pandey P, Schofield L, Israels S, Roncinske R, Yoshida K, Bharti A, Yuan Z-M, Saxena S, Weichselbaum R, Nalin C, Kufe D (1997) Role for Bcl-xL as an inhibitor of cytosolic cytochrome c accumulation in DNA damage-induced apoptosis. Proc Natl Acad Sci USA 94: 6939–6942
Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ (1995) Modulation of apoptosis by the widely distributed Bd-2 homologue Bak. Nature 374: 736–739
Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME (1995) Cytotoxicity-dependent APO-1 (Fas/CD95) - associated proteins form a death-inducing signaling complex ( DISC) with the receptor. EMBO J 14: 5579–5588
Kluck RM, Bossy Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for Bd-2 regulation of apoptosis. Science 275: 1132–1136
Knudson CM, Korsmeyer SJ (1997) Bd-2 and Bax function independently to regulate cell death. Nat Genet 16: 358–363
Knudson CM, Tung KSK, Tourtellotte WG, Brown GAJ, Korsmeyer SJ (1995) Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270: 96–99
Komiyama T, Ray CA, Pickup DJ, Howard AD, Thornberry NA, Peterson EP, Salvesen G (1994) Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. J Biol Chem 269: 19331–19337
Korsmeyer SJ (1992) Bd-2: a repressor of lymphocyte death. Immunol Today 13:285–288 Korsmeyer SJ (1995) Regulators of cell death. Trends Genet 11: 101–105
Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW (1993) MCLI, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to bc1–2. Proc Natl Acad Sci USA 90: 3516–3520
Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC (1993) Investigation of the subcellular distribution of the bc1–2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53: 4701–4714
Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC (1994a) Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bd-2. Am J Pathol 145: 1323–1336
Krajewski S, Krajewska M, Shabaik A, Wang HG, Irie S, Fong L, Reed IC (1994b) Immunohistochemical analysis of in vivo patterns of Bd-X expression. Cancer Res 54: 5501–5507
Krajewski S, Bodrug S, Krajewska M, Shabaik A, Gascoyne R, Berean K, Reed JC (1995) Immunohistochemical analysis of Mcl-1 protein in human tissues. Am J Pathol 146: 1309–1319
Krajewski S, Krajewska M, Reed JC (1996) Immunohistochemical analysis of in vivo patterns of bak expression, a proapoptotic member of the Bd-2 protein family. Cancer Res 56: 2849–2855
Kumar S (1995) ICE-like proteases in apoptosis. Trends Biochem Sci 20: 198–202
Kumar S, Lavin MF (1996) The ICE family of cysteine proteases as effectors of cell death. Cell Death Differ 3: 255–267
Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA (1994) Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-113-converting enzyme. Genes Dev 8: 1613–1626
Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T, Porteu A, Henrion A, Bouscary D, Varlet P, Joulin V, Kahn A (1996) Bd-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med 2: 80–86
Lagasse E, Weissman IL (1994) Bd-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J Exp Med 179: 1047–1052
Lagasse E, Weissman IL (1997) Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89: 1021–1031
Lin EY, Orlofsky A, Berger MS, Prystowsky MB (1993) Characterization of Al, a novel hemopoietic-specific early-response gene with sequence similarity to bc1–2. J Immunol 151: 1979–1988
Lin EY, Orlofsky A, Wang H-G, Reed JC, Prystowsky MB (1996) Al, a bd-2 family member, prolongs cell survival and permits myeloid differentiation. Blood 87: 983–992
Linette GP, Grusby MJ, Hedrick SM, Hansen TH, Glimcher LH, Korsmeyer SJ (1994) Bd-2 is upregulated at the CD4’CD8` stage during positive selection and promotes thymocyte differentiation at several control points. Immunity 1: 197–205
Linette GP, Hess JL, Sentman CL, Korsmeyer SJ (1995) Peripheral T-cell lymphoma in lckpr-bcl2 transgenic mice. Blood 86: 1255–1260
Linette GP, Li Y, Roth K, Korsmeyer SJ (1996) Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc Natl Acad Sci USA 93: 9545–9552
Lithgow T, van Driel R, Bertram JF, Strasser A (1994) The protein product of the oncogene bd-2 is a component of the nuclear envelope, the endoplasmic reticulum and the outer mitochondrial membrane. Cell Growth Differ 5: 411–417
Liu X, Kim CN, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147–157
Liu X, Zou H, Slaughter C, Wang X (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89: 175–184
Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847–849
Lynch DH, Watson ML, Alderson MR, Baum PR, Miller RE, Tough T, Gibson M, Davis-Smith T, Smith CA, Hunter K, Bhat D, Din W, Goodwin RG, Seldin MF (1994) The mouse fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1: 131–136
Macleod KF, Hu Y, Jacks T (1996) Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J 15: 6178–6188
Manji GA, Hozak RR, LaCount DJ, Friesen PD (1997) Baculovirus inhibitor of apoptosis functions at or upstream of the apoptotic suppressor p35 to prevent programmed cell death. J Virol 71: 4509–4516
Maraskovsky E, O’Reilly LA, Teepe M, Corcoran LM, Peschon JJ, Strasser A (1997) Bd-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1 mice. Cell 89: 1011–1019
Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M, Kroemer G (1996) Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 184: 1155–1160
Martinou I, Fernandez PA, Missotten M, White E, Allet B, Sadoul R, Martinou JC (1995) Viral proteins E1B19K and p35 protect sympathetic neurons from cell death induced by NGF deprivation. J Cell Biol 128: 201–208
Martinou J-C, Dubois-Dauphin M, Staple JK, Rodriguez I, Frankowski H, Missotten M, Albertini P, Talabot D, Catsicas S, Pietra C, Huarte J (1994) Overexpression of Bd-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13: 1017–1030
Marvel J, Perkins GR, Lopez-Rivas A, Collins MKL (1994) Growth factor starvation of bc1–2 overexpressing murine bone marrow cells induced refractoriness of IL-3 stimulation of proliferation. Oncogene 9: 1117–1122
Matsuzaki Y, Nakayama K-I, Nakayama K, Tomita T, Isoda M, Loh DY, Nakauchi H (1997) Role of bd-2 in the development of lymphoid cells from the hematopoietic stem cell. Blood 89: 853–862
Mazel S, Burtrum D, Petrie HT (1996) Regulation of cell division cycle progression by bc1–2 expression: a potential mechanism for inhibition of programmed cell death. J Exp Med 183: 2219–2226
McCurrach ME, Connor TMF, Knudson CM, Korsmeyer SJ, Lowe SW (1997) bax-deficiency promotes drug resistance and ongogenic transformation by attenuating p53-dependent apoptosis. Proc Natl Acad Sci USA 94: 2345–2349
McDonnell TJ, Korsmeyer SJ (1991) Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18) Nature 349: 254–256
McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP, Korsmeyer SJ (1989) bcl-2immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57: 79–88
McDonnell TJ, Nunez G, Platt FM, Hockenbery D, London L, McKearn JP, Korsmeyer SJ (1990) Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol Cell Biol 10: 1901–1907
Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC) EMBO J 16: 2794–2804
Memon SA, Moreno MB, Petrak D, Zacharchuk CM (1995) Bd-2 blocks glucocorticoid–but not Fas–or activation-induced apoptosis in a T cell hybridoma. J Immunol 115: 4644–4652
Merino R, Ding L, Veis DJ, Korsmeyer SJ, Nunez G (1994) Developmental regulation of the Bd-2 protein and susceptibility to cell death in B lymphocytes. EMBO J 13: 683–691
Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ (1994) Bd-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120: 301311
Minn AJ, Vélez P, Schendel SL, Liang H, Muchmore SW, Fesik SW, Fill M, Thompson CB (1997) Bcl-x, forms an ion channel in synthetic lipid membranes. Nature 385: 353–357
Miura M, Friedlander RM, Yuan J (1995) Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc Natl Acad Sci USA 92: 8318–8322
Miyashita T, Reed JC (1992) bd-2 gene transfer increases relative resistance of S49.1 and WEHI17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res 52: 5407–5411
Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC (1994) Tumor suppressor p53 is a regulator of bc1–2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799–1805
Monaghan P, Robertson D, Amos TAS, Dyer MJS, Mason DY, Greaves MF (1992) Ultrastructural localization of BCL-2 protein. J Histochem. Cytochem. 40: 1819–1825
Monica K, Chen Levy Z, Cleary ML (1990) Small G proteins are expressed ubiquitously in lymphoid cells and do not correspond to Bd-2. Nature 346: 189–191
Motoyama N, Wang FP, Roth KA, Sawa H, Nakayama K, Nakayama K, Negishi I, Senju S, Zhang Q, Fujii S, Loh DY (1995) Massive cell death of immature hematopoietic cells and neurons in Bd-x deficient mice. Science 267: 1506–1510
Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS, Nettesheim D, Chang BS, Thompson CB, Wong S-L, Ng S-C, Fesik SW (1996) X-ray and NMR structure of human Bc1x1, an inhibitor of programmed cell death. Nature 381: 335–341
Muzio M, Chinnaiyan AM, Kischkel FC, O’Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM (1996) FLICE, a novel FADD homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. Cell 85: 817–827
Nagata S (1997) Apoptosis by death factor. Cell 88: 355–365
Naik P, Karrim J, Hanahan D (1996) The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev 10: 2105–2116
Nakayama K, Nakayama K-I, Negishi I, Kuida K, Sawa H, Loh DY (1994) Targeted disruption of bc1–24 in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci USA 91: 3700–3704
Nakayama K-I, Nakayama K, Izumi N, Kuida K, Shinkai Y, Louie MC, Fields LE, Lucas PJ, Stewart V, Alt FW, Loh DY (1993) Disappearance of the lymphoid system in Bd-2 homozygous mutant chimeric mice. Science 261: 1884–1888
Naumovski L, Cleary ML (1996) The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M. Mol Cell Biol 16: 3884–3892
Nava VE, Cheng EH-Y, Veliuona M, Zou S, Clem RJ, Mayer ML, Hardwick JM (1997) Herpesvirus saimiri encodes a functional homolog of the human bc1–2 oncogene. J Virol 71: 4118–4122
Neilan JG, Lu Z, Alfonso CL, Kutish GF, Sussman MD, Rock DL (1993) An African swine fever virus gene with similarity to the proto-oncogene bd-2 and the Epstein-Barr virus gene BHRFI. J Virol 67: 4391–4394
Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL, Miller DK (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37–43
Nisitani S, Tsubata T, Murakami M, Okamoto M, Honjo T (1993) The bd-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow. J Exp Med 178: 1247–1254
Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ (1990) Deregulated Bd-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144: 3602–3610
O’Connor L, Strassar A, O’Reilly LA, Hausmann G, Adams J, Cory S, Huang DCS (1998) Bim: a novel member of the Bd-2 family that promotes apoptosis. EMBO J 17: 384–395
Oltvai ZN, Korsmeyer SJ (1994) Checkpoints of dueling dimers foil death wishes. Cell 79: 189–192
Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bd-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609–619
O’Reilly L, Huang DCS, Strasser A (1996) The cell death inhibitor Bd-2 and its homologues influence control of cell cycle entry. EMBO J 15: 6979–6990
O’Reilly LA, Harris AW, Strasser A (1997a) Bc1–2 transgene expression promotes survival and reduces proliferation of CD3–4–8– T cell progenitors. Int Immunol 9: 1291 – 1301
O’Reilly LA, Harris AW, Tarlinton DM, Corcoran LM, Strasser A (1997b) Expression of a bd-2 transgene reduces proliferation and slows turnover of developing B cells in vivo. J Immunol 159: 2301–2311
Orkin SH (1996) Development of the hematopoietic system. Curr Opin Genet Dev 6: 597602
Parker MW, Pattus F (1993) Rendering a membrane protein soluble in water: a common packing motif in bacterial protein toxins. TIBS 18: 391–395
Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, D Agati V, Orkin SH, Costantini F (1991) Erythroid differentiation in chimeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349: 257–260
Raff MC (1992) Social controls on cell survival and cell death. Nature 356: 397–400
Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, Perucho M (1997) Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275: 967–969
Ray CA, Black RA, Kronheim SR, Greenstreet GS, Pickup DJ (1992) Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1(i converting enzyme. Cell 69: 597–604
Reed JC (1994) Bd-2 and the regulation of programmed cell death. J Cell Biol 124: 1–6
Reed JC (1996) Mechanisms of Bd-2 family protein function and dysfunction in health and disease. Behring Inst Mitt 97: 72–100
Reed JC (1997) Double identity for proteins of the Bd-2 family. Nature 387: 773–776
Reed JC, Miyashita T, Takayama S, Wang H-G, Sato T, Krajewski S, Aimé-Sempé C, Bodrug S, Kitada S, Hanada M (1996) BCL-2 family proteins: regulators of cell death involved in the
Reed JC, Miyashita T, Takayama S, Wang H-G, Sato T, Krajewski S, Aimé-Sempé C, pathogenesis of cancer and resistance to therapy. J Cell Biochem 60:23–32
Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IAG, Debatin KM, Fischer A, de Villartay JP (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347–1349
Rodel JE, Link DC (1996) Suppression of apoptosis during cytokine deprivation of 32D cells is not sufficient to induce complete granulocytic differentiation. Blood 87: 858–864
Rodriguez I, Matsuura K, Khatib K, Reed JC, Nagata S, Vassalli P (1996) A bd-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. J Exp Med 183: 1031–1036
Rodriguez I, Araki K, Khatib K, Martinou J-C, Vassalli P (1997) Mouse vaginal opening is an apoptosis-dependent process which can be prevented by the overexpression of Bc12. Dev Biol 184: 115–121
Rotonda J, Nicholson DW, Fazil KM, Gallant M, Gareau Y, Labelle M, Peterson EP, Rasper DM, Ruel R, Vaillancourt JP, Thornberry NA, Becker JW (1996) The three-dimensional structure of apopain/cpp32, a key mediator of apoptosis. Nat Struct Biol 3: 619–625
Rudel T, Bokoch GM (1997) Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276: 1571–1574
Russell JH, Wang R (1993) Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells. Eur J Immunol 23: 2379–2382
Russell JH, Rush B, Weaver C, Wang R (1993) Mature T cells of autoimmune 1pr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 90: 4409–4413
Sarid R, Sato T, Bohenzky RA, Russo JJ, Chang Y (1997) Kaposi’s sarcoma-associated herpesvirus encodes a functional Bd-2 homologue. Nat Med 3: 293–298
Sattler M, Liang H, Nettesheim D, Meadows RP, Harlan JE, Eberstadt M, Yoon HS, Shuker SB, Chang BS, Minn AJ, Thompson CB, Fesik SW (1997) Structure of Bcl-x1-Bak peptide complex: recognition between regulators of apoptosis. Science 275: 983–986
Savill J, Fadok V, Henson P, Haslett C (1993) Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14: 131–136
Schendel SL, Xie Z, Oblatt Montal M, Matsuyama S, Montal M, Reed JC (1997) Channel formation by antiapoptotic protein Bc1–2. Proc Natl Acad Sci USA 94: 5113–5118
Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB, Korsmeyer SJ (1995) Multiple Bd-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci USA 92: 7834–7838
Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ (1991) bd-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67: 879–888
Seshagiri S, Miller LK (1997) Caenorhabditis elegans CED-4 stimulates CED-3 processing and CED-3-induced apoptosis. Curr Biol 7: 455–460
Shibasaki F, Kondo E, Akagi T, McKeon F (1997) Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bd-2. Nature 386: 728–731
Shimizu S, Eguchi Y, Kosaka H, Kamiike W, Matsuda H, Tsujimoto Y (1995) Prevention of hypoxia-induced cell death by Bd-2 and Bcl-xL. Nature 374: 811–813
Siegel RM, Katsumata M, Miyashita T, Louie DC, Greene MI, Reed JC (1992) Inhibition of thymocyte apoptosis and negative antigenic selection in bd-2 transgenic mice. Proc Natl Acad Sci USA 89: 7003–7007
Silva M, Grillot D, Benito A, Richard C, Nunez G, Fernandez-Luna JL (1996) Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-X1 and Bd-2. Blood 88: 1576–1582
Simonian PL, Grillot DAM, Andrews DW, Leber B, Nunez G (1996a) Bax homodimerization is not required for Bax to accelerate chemotherapy-induced cell death. J Biol Chem 271: 32073–32077
Simonian PL, Grillot DAM, Merino R, Nunez G (1996b) Bax can antagonize Bcl-X, during etoposide and cisplatin-induced cell death independently of its heterodimerization wtih Bd-XL. J Biol Chem 271: 22764–22772
Smith KGC, Weiss U, Rajewsky K, Nossal GJV, Tarlinton DM (1994) BCL-2 increases memory B cell recruitment but does not perturb selection in germinal centers. Immunity 1: 808–813
Smith KGC, Strasser A, Vaux DL (1996) CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J 15: 5167–5176
Song Z, McCall K, Steller H (1997) DCP-1 a Drosophila cell death protease essential for development. Science 275: 536–540
Spector MS, Desnoyers S, Hoeppner DJ, Hengartner MO (1997) Interaction between the C. elegans cell-death regulators CED-9 and CED-4. Nature 385: 653–656
Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, Alnemri ES (1996) Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci USA 93: 14486–14491
Steller H (1995) Mechanisms and genes of cellular suicide. Science 267: 1445–1449
Strasser A (1995a) Death of a T cell. Nature 373: 385–386
Strasser A (1995b) Life and death during lymphocyte development and function: evidence for two distinct killing mechanisms. Curr Opin Immunol 7: 228–234
Strasser A, Anderson RL (1995) Bd-2 and thermotolerance cooperate in cell survival. Cell Growth Differ 6: 799–805
Strasser A, Harris AW, Bath ML, Cory S (1990a) Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bd-2. Nature 348: 331–333
Strasser A, Harris AW, Vaux DL, Webb E, Bath ML, Adams JM, Cory S (1990b) Abnormalities of the immune system induced by dysregulated bd-2 expression in transgenic mice. Curr Top Microbiol Immunol 166: 175–181
Strasser A, Harris AW, Cory S (199la) Bd-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67: 889–899
Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S, Harris AW (1991b) Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 88: 8661–8665
Strasser A, Harris AW, Cory S (1992) The role of bd-2 in lymphoid differentiation and transformation. Curr Top Microbiol Immunol 182: 299–302
Strasser A, Harris AW, Cory S (1993) Eµ-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. Oncogene 8: 1–9
Strasser A, Harris AW, Corcoran LM, Cory S (1994a) bd-2 expression promotes B but not T lymphoid development in scid mice. Nature 368: 457–460
Strasser A, Harris AW, Jacks T, Cory S (1994b) DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bd-2. Cell 79: 329–339
Strasser A, Harris AW, Von Boehmer H, Cory S (1994c) Positive and negative selection of T cells in T cell receptor transgenic mice expressing a bd-2 transgene. Proc Natl Acad Sci USA 91: 1376–1380
Strasser A, Harris AW, Huang DCS, Krammer PH, Cory S (1995) Bd-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 14: 6136–6147
Strasser A, O’Connor L, Huang DCS, O’Reilly LA, Stanley ML, Bath ML, Adams JM, Cory S, Harris AW (1996) Lessons from bd-2 transgenic mice for immunology, cancer biology and cell death research. Behring Inst Mitt 97: 101–117
Strasser A, Huang DCS, Vaux DL (1997) The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control in tumourigenesis and resistance to chemotherapy. Biochim Biophys Acta 1333: F151 - F178
Strobel T, Swanson L, Korsmeyer S, Cannistra SA (1996) BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proc Natl Acad Sci USA 93: 14094–14099
Sugimoto A, Friesen PD, Rothman JH (1994) Baculovirus p35 prevents developmentally programmed cell death and rescues a ced-9 mutant in the nematode Caenorhabditis elegans. EMBO J 13: 2023–2028
Sulston JE, Horvitz HR (1977) Postembryonic cell lineages of the nematode Caenorhabditis elegans. Dev Biol 56: 110–156
Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969–976
Takahashi T, Honda H, Hirai H, Tsujimoto Y (1997) Overexpressed Bcl-x, prevents bacterial superantigen-induced apoptosis of thymocytes in vitro. Cell Death Differ 4: 159–165
Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Milian JA, Reed JC (1995) Cloning and functional analysis of BAG-1: a novel Bc1–2-binding protein with anti-cell death activity. Cell 80: 279–284
Talley AK, Dewhurst S, Perry SW, Dollard SC, Gummuluru S, Fine SM, New D, Epstein LG, Gendelman HE, Gelbard HA (1995) Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bd-2 and crmA. Mol Cell Biol 15: 2359–2366
Tao W, Teh S-J, Melhado I, Jirik F, Korsmeyer SJ, Teh H-S (1994) The T cell receptor repertoire of CD4–8’ thymocytes is altered by overexpression of the BCL-2 protooncogene in the thymus. J Exp Med 179: 145–153
Tarlinton DM, Corcoran LM, Strasser A (1997) Cell survival and cell differentiation during B lymphopoiesis are subject to distinct control. Int Immunol 9: 1481–1494
Tartaglia LA, Ayres TM, Wong GHW, Goeddel DV (1993) A novel domain within the 55k TNF receptor signals cell death. Cell 74: 845–853
Tewari M, Dixit VM (1995) Fas-and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 270: 3255–3260
Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT, Nicholson DW (1997) A combinatorial approach defines specificities of members of the caspase family and granzyme B. J Biol Chem 272: 17907–17911
Tsujimoto Y (1989) Stress-resistance conferred by high level of bd-2 alpha protein in human B lymphoblastoid cell. Oncogene 4: 1331–1336
Tsujimoto Y, Croce CM (1986) Analysis of the structure, transcripts, and protein products of bc1- 2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83: 5214–5218
Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226: 1097–1099
Tsujimoto Y, Ikegaki N, Croce CM (1987) Characterization of the protein product of bd-2, the gene involved in human follicular lymphoma. Oncogene 2: 3–7
Vairo G, Innes KM, Adams JM (1996) Bc1–2 has a cell cycle inhibitory function separable from its enhancement of cell survival. Oncogene 13: 1511–1519
Vanhaesebroeck B, Reed JC, de Valck D, Grooten J, Miyashita T, Tanaka S, Beyaert R, van Roy F, Fiers W (1993) Effect of bc1–2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity. Oncogene 8: 1075–1081
Vaux DL, Strasser A (1996) The molecular biology of apoptosis. Proc Natl Acad Sci USA 93: 2239–2244
Vaux DL, Cory S, Adams JM (1988) Bd-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440–442
Vaux DL, Haecker G, Strasser A (1994) An evolutionary perspective on apoptosis. Cell 76: 777–779
Vaux DL, Weissman IL, Kim SK (1992) Prevention of programmed cell death in Caenorhabditis elegans by human bc1–2. Science 258: 1955–1957
Veis DJ, Sentman CL, Bach EA, Korsmeyer SJ (1993a) Expression of the Bc1–2 protein in murine and human thymocytes and in peripheral T lymphocytes. J Immunol 151: 2546–2554
Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ (1993b) Bc1–2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75: 229–240
Walker NPC, Talanian RV, Brady KD, Dang LC, Bump NJ, Ferenz CR, Franklin S, Ghayur T, Hackett MC, Hammill LD, Herzog L, Hugunin M, Houy W, Mankovich JA, McGuiness L, Orlewicz E, Paskind M, Pratt CA, Reis P, Summani A, Terranova M, Welch JP, Xiong L, Moller A, Tracey DE, Kamen R, Wong WW (1994) Crystal structure of cysteine protease interleukin1(3-converting enzyme: a (p20/p10)Z homodimer. Cell 78: 343–352
Walton MI, Whysong D, O’Connor PM, Hockenbery D, Korsmeyer SJ, Kohn KW (1993) Constitutive expression of human Bd-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res 53: 1853–1861
Wang H-G, Rapp UR, Reed JC (1996a) Bd-2 targets the protein kinase Raf-1 to mitochondria. Cell 87: 629–638
Wang K, Yin X-M, Chao DT, Milliman CL, Korsmeyer SJ (1996b) BID: a novel BH3 domain-only death agonist. Genes Dev 10: 2859–2869
Wang L, Miura M, Bergeron L, Zhu H, Yuan J (1994) Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78: 739–750
Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314–317
White E (1996) Life, death, and the pursuit of apoptosis. Genes Dev 10: 1–15
White E, Sabbatini P, Debbas M, Wold WSM, Kusher DI, Gooding LR (1992) The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor a. Mol Cell Biol 12: 2570–2580
White K, Tahaoglu E, Steller H (1996) Cell killing by the Drosophila gene reaper. Science 271: 805807
Wilson KP, Black J-A F, Thomson JA, Kim EE, Griffith JP, Navia MA, Murcko MA, Chambers SP, Aldape RA, Raybuck SA, Livingston DJ (1994) Structure and mechanism of interleukin-1(3 converting enzyme. Nature 370: 270–275
Wu D, Wallen HD, Nunez G (1997) Interaction and regulation of subcellular localization of CED-4 by CED-9. Science 275: 1126–1129
Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555–556
Wyllie AH, Kerr JFR, Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68: 251–306
Xiang J, Chao DT, Korsmeyer SJ (1996) BAX-induced cell death may not require interleukin 113-converting enzyme-like proteases. Proc Natl Acad Sci USA 93: 14559–14563
Xue D, Horvitz HR (1995) Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature 377: 248–251
Yang E, Korsmeyer SJ (1996) Molecular thanatopsis: a discourse on the Bd-2 family and cell death. Blood 88: 386–401
Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ (1995) Bad, a heterodimeric partner for Bc1-xL and Bd-2, displaces Bax and promotes cell death. Cell 80: 285–291
Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T-I, Jones DP, Wang X (1997) Prevention of apoptosis by Bd-2: release of cytochrome c from mitochondria blocked. Science 275: 1129–1132
Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T (1997) Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385: 637–640
Yin X-M, Oltvai ZN, Korsmeyer SJ (1994) BH1 and BH2 domains of Bc1–2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369: 321–323
Young F, Mizoguchi E, Bhan AK, Alt FW (1997) Constitutive Bd-2 expression during immunoglobulin heavy chain-promoted B cell differentiation expands novel precursor B cells. Immunity 6: 23–33
Yuan J, Horvitz HR (1992) The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death. Development 116: 309–320
Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-113-converting enzyme. Cell 75: 641–652
Zha H, Aimé-Sempé C, Sato T, Reed JC (1996a) Proapoptotic protein Bax heterodimerizes with Bd-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J Biol Chem 271: 7440–7444
Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ (1996b) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14–3–3 not BCL–XL. Cell 87: 619 – 628
Zhou Q, Snipas S, Orth K, Muzio M, Dixit VM, Salvesen GS (1997) Target protease specificity of the viral serpin CrmA. J Biol Chem 272: 7797–7800
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
O’Connor, L., Strasser, A. (1999). The Bcl-2 Protein Family. In: Kumar, S. (eds) Apoptosis: Biology and Mechanisms. Results and Problems in Cell Differentiation, vol 23. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69184-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-540-69184-6_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-21623-1
Online ISBN: 978-3-540-69184-6
eBook Packages: Springer Book Archive